USE OF A COMBINATION OF METHOTREXATE AND AN A3AR AGONIST FOR THE TREATMENT OF CANCER

摘要

The therapeutic treatment of cancer by a combined administration of methotrexate and an agonist of the A3 adenosine receptor. Provided are pharmaceutical compositions comprising such a combined administration useful in the therapeutic treatment of cancer as well as the use of any of these active agents for preparing such a pharmaceutical composition.